monoclonal anti-cd303 antibody
mAbexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 20, 2017 (NCT03370627)
Timeline
No events for the selected filters.
Mechanism of action
CLEC4C inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03370627 | N/A | Dec 20, 2017 | Laboratoire français de Fractionnement et de Biotechnologies, University of Lille |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Laboratoire français de Fractionnement et de Biotechnologies | For profit | 1 | 0 | 1 | 2017 |
| University of Lille | Academic/Hospital | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1